The study will compare the effectiveness of published patient-specific three-dimensional anatomical models for preoperative planning and tumor excision compared to existing popular care, which relies solely on CT or MRI imaging. The announcement made at last week’s RAPID TCT event.
This joint study aims to demonstrate prospective innovations in surgical outcomes, such as reduced blood loss, shorter operative times, and reduced threat of headaches during the procedure, when three-dimensional models are published. To this end, studies will compare clinical outcomes between an experiment organization in which tumors are removed, 3D published models along with imaging for planning, and an active comparison organization in which tumor excision will be ready by imaging alone.
Due to their capabilities in the healthcare field, Stratasys and Ricoh believe that the advantages of 3D printed models in preoperative planning are manifold and have a positive effect on both doctors and patients. , recommend that physicians and surgeons benefit from developing improved and better-informed pre-surgical plans, making complex procedures “more efficient, more cost-effective, and faster. “The use of 3D printing can allow clinicians to construct important facets of the patient’s anatomy with life-size physical replicas, helping them to better simulate procedures and improve excision accuracy. In turn, this can help improve patient outcomes and recovery.
“The collaboration brings an unprecedented combination of expertise and innovation in medical imaging and 3D printing and, if successful, could identify anatomical models as a novelty for treating patients during bone tumor ablation,” said Erez Ben Zvi, vice president of physician at Stratasys.
Gary Turner, General Manager of Additive Manufacturing at Ricoh USA, Inc. , added, “We are excited to co-sponsor this important clinical trial alongside our long-standing Stratasys partners to further demonstrate the potential effect of 3 specific patients. “-D modeling and also drive the adoption of this generation to better serve a wider population.
The clinic jointly announced through Stratasys and Ricoh USA will be a prospective, multicenter, randomized, controlled matrix. It is expected to last 12 months and involve up to 150 subjects at 3 sites, two of which have already been confirmed: The Ohio State University Wexner Medical Center and Corewell Health.
“Our never-ending project is aimed at patient outcomes, and that starts with pre-operative planning,” Kyle K said. Van Koevering, Associate Professor of Medicine, Otolaryngology – Head and Neck Surgery, Ohio State Wexner Medical Center. “We look to the future to participate in this Study to Read about how published 3D models can help medical staff better prepare for surgery and educate the patient. “
“Being one of the sites participating in this study puts us at the forefront of demonstrating new technologies that can improve patient care and fitness outcomes,” said Aws Hammad, M. D. , Clinical School of Orthopedic Surgery at Corewell Health William Beaumont University Hospital. “Addressing the demanding situations of bone sarcomas and employing the strength of patient-specific three-dimensional modeling is a vital step not only in patient education, but also in assisting surgeons with more precise surgical procedures. “
© Rapid News Publications Ltd. A Rapid News Group company. All rights reserved